Upgrade to SI Premium - Free Trial

Innoviva (INVA) and GSK (GSK) Announce Trelegy Ellipta Receives Positive CHMP Opinion Supporting Expanded COPD Indication

September 21, 2018 7:31 AM
GlaxoSmithKline plc (NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA

Next Articles